Organization
Sichuan Cancer hospital institute, Chengdu, China
1 abstract
Abstract
Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenter-based real-world study.Org: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Sichuan Cancer hospital institute, Chengdu, China, Department of Oral and Maxillofacial Head & Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China, PLA General Hospital, Beijing, China, Sun Yat-sen University Cancer Center, Guangzhou, China,